Accordingly, treatment of cancer cells with JBI-097 resulted in a stronger and complete inhibition of cell proliferation as compared to LSD1 or HDAC6 specific inhibitors, clearly demonstrating the advantage of dual inhibition. Here, HDAC6 is linked to cancer.